302 related articles for article (PubMed ID: 25262802)
1. Anthrax lethal factor inhibitors as potential countermeasure of the infection.
Kumar BV; Malik S; Grandhi P; Dayam R; Sarma JA
Curr Top Med Chem; 2014; 14(17):1977-89. PubMed ID: 25262802
[TBL] [Abstract][Full Text] [Related]
2. Anthrax toxin: a tripartite lethal combination.
Ascenzi P; Visca P; Ippolito G; Spallarossa A; Bolognesi M; Montecucco C
FEBS Lett; 2002 Nov; 531(3):384-8. PubMed ID: 12435580
[TBL] [Abstract][Full Text] [Related]
3. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.
Tonello F; Montecucco C
Mol Aspects Med; 2009 Dec; 30(6):431-8. PubMed ID: 19665472
[TBL] [Abstract][Full Text] [Related]
4. Anthrax toxin.
Bhatnagar R; Batra S
Crit Rev Microbiol; 2001; 27(3):167-200. PubMed ID: 11596878
[TBL] [Abstract][Full Text] [Related]
5. Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxin.
Bromberg-White J; Lee CS; Duesbery N
Toxins (Basel); 2010 May; 2(5):1038-53. PubMed ID: 22069624
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight inhibitors of the protease anthrax lethal factor.
Dalkas GA; Papakyriakou A; Vlamis-Gardikas A; Spyroulias GA
Mini Rev Med Chem; 2008 Mar; 8(3):290-306. PubMed ID: 18336349
[TBL] [Abstract][Full Text] [Related]
7. Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity.
Panchal RG; Halverson KM; Ribot W; Lane D; Kenny T; Abshire TG; Ezzell JW; Hoover TA; Powell B; Little S; Kasianowicz JJ; Bavari S
J Biol Chem; 2005 Mar; 280(11):10834-9. PubMed ID: 15644338
[TBL] [Abstract][Full Text] [Related]
8. Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.
Karginov VA; Nestorovich EM; Moayeri M; Leppla SH; Bezrukov SM
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15075-80. PubMed ID: 16214885
[TBL] [Abstract][Full Text] [Related]
9. Role of toxin functional domains in anthrax pathogenesis.
Brossier F; Weber-Levy M; Mock M; Sirard JC
Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564
[TBL] [Abstract][Full Text] [Related]
10. Identification of small molecule inhibitors of anthrax lethal factor.
Panchal RG; Hermone AR; Nguyen TL; Wong TY; Schwarzenbacher R; Schmidt J; Lane D; McGrath C; Turk BE; Burnett J; Aman MJ; Little S; Sausville EA; Zaharevitz DW; Cantley LC; Liddington RC; Gussio R; Bavari S
Nat Struct Mol Biol; 2004 Jan; 11(1):67-72. PubMed ID: 14718925
[TBL] [Abstract][Full Text] [Related]
11. Anthrax Pathogenesis.
Moayeri M; Leppla SH; Vrentas C; Pomerantsev AP; Liu S
Annu Rev Microbiol; 2015; 69():185-208. PubMed ID: 26195305
[TBL] [Abstract][Full Text] [Related]
12. Insights into the anthrax lethal factor-substrate interaction and selectivity using docking and molecular dynamics simulations.
Dalkas GA; Papakyriakou A; Vlamis-Gardikas A; Spyroulias GA
Protein Sci; 2009 Aug; 18(8):1774-85. PubMed ID: 19585464
[TBL] [Abstract][Full Text] [Related]
13. Toxins of Bacillus anthracis.
Brossier F; Mock M
Toxicon; 2001 Nov; 39(11):1747-55. PubMed ID: 11595637
[TBL] [Abstract][Full Text] [Related]
14. Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates.
Kurbanov EK; Chiu TL; Solberg J; Francis S; Maize KM; Fernandez J; Johnson RL; Hawkinson JE; Walters MA; Finzel BC; Amin EA
J Med Chem; 2015 Nov; 58(21):8723-33. PubMed ID: 26492514
[TBL] [Abstract][Full Text] [Related]
15. [Anthrax toxins].
Brossier F; Guidi-Rontani C; Mock M
C R Seances Soc Biol Fil; 1998; 192(3):437-44. PubMed ID: 9759382
[TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
Stiles L; Nelson DJ
J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
[TBL] [Abstract][Full Text] [Related]
17. Anthrax lethal factor inhibition.
Shoop WL; Xiong Y; Wiltsie J; Woods A; Guo J; Pivnichny JV; Felcetto T; Michael BF; Bansal A; Cummings RT; Cunningham BR; Friedlander AM; Douglas CM; Patel SB; Wisniewski D; Scapin G; Salowe SP; Zaller DM; Chapman KT; Scolnick EM; Schmatz DM; Bartizal K; MacCoss M; Hermes JD
Proc Natl Acad Sci U S A; 2005 May; 102(22):7958-63. PubMed ID: 15911756
[TBL] [Abstract][Full Text] [Related]
18. Manipulation of host signalling pathways by anthrax toxins.
Turk BE
Biochem J; 2007 Mar; 402(3):405-17. PubMed ID: 17313374
[TBL] [Abstract][Full Text] [Related]
19. Anthrax lethal factor and edema factor act on conserved targets in Drosophila.
Guichard A; Park JM; Cruz-Moreno B; Karin M; Bier E
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3244-9. PubMed ID: 16455799
[TBL] [Abstract][Full Text] [Related]
20. Anthrax toxin lethal factor domain 3 is highly mobile and responsive to ligand binding.
Maize KM; Kurbanov EK; De La Mora-Rey T; Geders TW; Hwang DJ; Walters MA; Johnson RL; Amin EA; Finzel BC
Acta Crystallogr D Biol Crystallogr; 2014 Nov; 70(Pt 11):2813-22. PubMed ID: 25372673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
